Surgery Partners (NASDAQ: SGRY) insider transactions
In the twelve months to 10 November 2026, executives and directors of Surgery Partners reported 12 open-market sales of 96,896 shares ($1.3m) and 1 open-market purchase of 10,000 shares ($143,500), by 7 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 18 August 2026 | DeLuca Teresa | Director | Open-market purchase | +10,000 | $14.35 | 66,843 | Form 4 |
| 18 June 2026 | Hendrix Blair E | Director | Grant or award | +34,364 | $14.55 | 52,895 | Form 4 |
| 5 June 2026 | Turner Brent | Director | Grant or award | +11,670 | $13.71 | 86,594 | Form 4 |
| 5 June 2026 | DeLuca Teresa | Director | Grant or award | +11,670 | $13.71 | 56,843 | Form 4 |
| 5 June 2026 | Dean Lloyd H | Director | Grant or award | +11,670 | $13.71 | 11,670 | Form 4 |
| 5 June 2026 | Adlerz Clifford G | Director | Grant or award | +11,670 | $13.71 | 69,104 | Form 4 |
| 5 June 2026 | Forese Laura L | Director | Grant or award | +11,670 | $13.71 | 18,531 | Form 4 |
| 5 June 2026 | Deane John A | Director | Grant or award | +11,670 | $13.71 | 45,922 | Form 4 |
| 5 June 2026 | Hendrix Blair E | Director | Grant or award | +11,670 | $13.71 | 18,531 | Form 4 |
| 16 March 2026 | Evans Jason Eric | Chief Executive Officer | Open-market sale | −20,400 | $12.47 | 920,386 | Form 4 |
| 16 March 2026 | Doherty David T | Chief Financial Officer | Open-market sale | −8,867 | $12.50 | 221,679 | Form 4 |
| 13 March 2026 | Brittenham Marissa | Chief Strategy Officer | Open-market sale | −3,657 | $12.54 | 94,196 | Form 4 |
| 13 March 2026 | Burkhalter Danielle | Chief Human Resources Officer | Open-market sale | −3,469 | $12.83 | 76,864 | Form 4 |
| 12 March 2026 | Baldock Jennifer | Chief Admin & Dev Officer | Open-market sale | −5,798 | $13.17 | 326,474 | Form 4 |
| 6 March 2026 | Brittenham Marissa | Chief Strategy Officer | Open-market sale | −8,785 | $13.70 | 54,623 | Form 4 |
| 6 March 2026 | Webb William Trenton | American Group President | Open-market sale | −272 | $13.93 | 74,249 | Form 4 |
| 6 March 2026 | Burkhalter Danielle | Chief Human Resources Officer | Open-market sale | −7,736 | $13.60 | 37,103 | Form 4 |
| 6 March 2026 | Baldock Jennifer | Chief Admin & Dev Officer | Open-market sale | −10,082 | $13.70 | 332,272 | Form 4 |
| 6 March 2026 | Doherty David T | Chief Financial Officer | Open-market sale | −14,574 | $13.84 | 88,803 | Form 4 |
| 6 March 2026 | Evans Jason Eric | Chief Executive Officer | Open-market sale | −11,462 | $13.79 | 662,680 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Surgery Partners page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.